Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Optical Workings: Specialists Must Communicate to Treat Eye Disease

  |  

Richard Quinn is a freelance writer in New Jersey.

References

ADVERTISEMENT
SCROLL TO CONTINUE
  1. AbbVie Inc. News release: AbbVie’s HUMIRA (adalimumab) receives U.S. Food and Drug Administration approval to treat adults with non-infectious intermediate, posterior and panuveitis. 2016 Jun 30.
  2. AbbVie Inc. News release: AbbVie receives orphan drug designation for Humira (adalimumab) from the U.S. Food and Drug Administration for the investigational treatment of certain forms of non-infectious uveitis. 2014 May 20.

Related Articles

    An Overview of Pediatric, Noninfectious Uveitis

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    Watch Those Eyes

    What you need to know about Uveitis in Rheumatic Diseases

    ARZTSAMUI / shutterstock.com

    Uveitis: A Brief Primer for the Rheumatologist

    Uveitis is an umbrella term for intraocular inflammatory diseases that can lead to vision loss. It’s not just a concern for ophthalmologists. Uveitis occurs in approximately 2–5% of patients with inflammatory bowel disease, 6–9% of patients with psoriatic arthritis and 25% of patients with reactive arthritis. The prevalence may be as high as 33% in…

    Stock Footage Inc / shutterstock.com

    ACR, Ophthalmologists & Dermatologists Issue Joint Hydroxychloroquine Statement

    Since 1991, hydroxychloroquine (HCQ) has been a staple for the treatment of patients with systemic lupus erythematosus; it has been shown to improve survival, reduce cardiovascular risk, thrombosis and renal damage, delay or prevent lupus cerebritis and more. However, HCQ can potentially bind in the retinal pigment epithelium and cause degeneration of photoreceptors, leading to…